Cargando…
Effective gene therapy of Stargardt disease with PEG-ECO/pGRK1-ABCA4-S/MAR nanoparticles
Stargardt disease (STGD) is the most common form of inherited retinal genetic disorders and is often caused by mutations in ABCA4. Gene therapy has the promise to effectively treat monogenic retinal disorders. However, clinically approved adeno-associated virus (AAV) vectors do not have a loading ca...
Autores principales: | Sun, Da, Sun, Wenyu, Gao, Song-Qi, Lehrer, Jonathan, Naderi, Amirreza, Wei, Cheng, Lee, Sangjoon, Schilb, Andrew L., Scheidt, Josef, Hall, Ryan C., Traboulsi, Elias I., Palczewski, Krzysztof, Lu, Zheng-Rong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9463552/ https://www.ncbi.nlm.nih.gov/pubmed/36159595 http://dx.doi.org/10.1016/j.omtn.2022.08.026 |
Ejemplares similares
-
Optimization of Synthesis of the Amino Lipid ECO for Effective Delivery of Nucleic Acids
por: Schilb, Andrew L., et al.
Publicado: (2021) -
Macular hyperpigmentary changes in ABCA4-Stargardt disease
por: Abalem, Maria Fernanda, et al.
Publicado: (2019) -
Novel ABCA4 compound heterozygous mutations cause severe progressive autosomal recessive cone-rod dystrophy presenting as Stargardt disease
por: Xi, Quansheng, et al.
Publicado: (2009) -
Cell-Type-Specific Complement Profiling in the ABCA4(−/−) Mouse Model of Stargardt Disease
por: Jabri, Yassin, et al.
Publicado: (2020) -
Variants in the ABCA4 gene in a Brazilian population with Stargardt disease
por: Salles, Mariana Vallim, et al.
Publicado: (2018)